J. Pomonis

发表

Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats

A. Levine, C. Billington, J. Pomonis, 1996, Neuroreport.

Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain.

A. Levine, C. Billington, C. Kotz, 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain

P. Mantyh, T. Yaksh, J. Pomonis, 2002, Pain.

BCTC (N-(4-tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropryazine- 1(2H)-carbox-amide), a novel, orally-effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain

Valenzano, J. Pomonis, D. Bristol, 2003 .

Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein.

A. Levine, C. Billington, C. Kotz, 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

Proteomic analysis of the reactive phenotype of astrocytes following endothelin‐1 exposure

P. Mantyh, Julie A. Schmidt, J. Pomonis, 2003, Proteomics.

Endothelin receptor expression in the normal and injured spinal cord: potential involvement in injury-induced ischemia and gliosis

P. Mantyh, Julie A. Schmidt, J. Pomonis, 2003, Experimental Neurology.

PII: S0304-3959(02)00102-1

P. Mantyh, T. Yaksh, J. Pomonis, 2002 .

Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur

P. Mantyh, J. Pomonis, D. Clohisy, 2002, Neuroscience.

DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: II. In Vivo Pharmacological Characterization in the Rat

J. Pomonis, Y. Rotshteyn, K. Walker, 2004, Journal of Pharmacology and Experimental Therapeutics.

DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat.

M. Fundytus, J. Pomonis, Y. Rotshteyn, 2004, The Journal of pharmacology and experimental therapeutics.

N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain

J. Pomonis, D. Bristol, K. Valenzano, 2003, Journal of Pharmacology and Experimental Therapeutics.

Preclinical Pharmacological Approaches in Drug Discovery for Chronic Pain.

J. Pomonis, J. Kennedy, G. Whiteside, 2016, Advances in pharmacology.

Discriminative stimulus effects of morphine: central versus peripheral training

J. Cleary, J. Hofmeister, A. Levine, 1999, Brain Research.

Expression and Localization of Endothelin Receptors: Implications for the Involvement of Peripheral Glia in Nociception

P. Mantyh, J. Pomonis, J. Ghilardi, 2001, The Journal of Neuroscience.

An industry perspective on the role and utility of animal models of pain in drug discovery

J. Pomonis, Garth T. Whiteside, James D. Pomonis, 2013, Neuroscience Letters.

Endothelin and the tumorigenic component of bone cancer pain

P. Mantyh, J. Pomonis, J. Ghilardi, 2004, Neuroscience.

Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain

Jason G. Jin, D. Lavery, Rui-Ru Ji, 2008, PAIN®.

Development and pharmacological characterization of a rat model of osteoarthritis pain

J. Pomonis, K. Walker, T. Bunton, 2005, Pain.

Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS

P. Mantyh, J. Pomonis, H. Hagiwara, 2003, Glia.

Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior

P. Olszewski, A. Levine, C. Billington, 2004, Brain Research.

TRPV1 antagonists and chronic pain

J. Pomonis, K. Valenzano, K. Walker, 2005 .

Intrahypothalamic Discriminative Stimulus Effects of Neuropeptide Y

J. Cleary, A. Levine, C. Billington, 1998, Pharmacology Biochemistry and Behavior.

Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties : II . In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain

J. Pomonis, D. Bristol, K. Valenzano, 2003 .

The monosodium iodoacetate model of osteoarthritis pain in the rat.

J. Pomonis, Cheryl L. Marker, 2012, Methods in molecular biology.

Pharmacology of 2-[4-(4-Chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: A Potent, Broad-Spectrum State-Dependent Sodium Channel Blocker for Treating Pain States

R. B. Carter, J. Pomonis, D. Hogenkamp, 2006, Journal of Pharmacology and Experimental Therapeutics.

Interaction of the Hypothalamic Paraventricular Nucleus and Central Nucleus of the Amygdala in Naloxone Blockade of Neuropeptide Y-Induced Feeding Revealed by c-fos Expression

A. Levine, C. Billington, J. Pomonis, 1997, The Journal of Neuroscience.